Assignee
SDF BIOPHARMA INC
US·5 granted patents·2 pending applications·0 citations·filing 2018–2024
Top patents by PatentIndex Score
7 records- 0186US2024360418A1Methods for reducing elevated glucose levelsSDF BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 0285US12365876B2Genetically modified stem cellsSDF BIOPHARMA INC·Filed 2023·Granted Jul 22, 2025·0 cites·28 claims
- 0377US11739298B2Genetically modified stem cellsSDF BIOPHARMA INC·Filed 2021·Granted Aug 29, 2023·0 cites·10 claims
- 0474US11186827B1Genetically modified stem cellsSDF BIOPHARMA INC·Filed 2021·Granted Nov 30, 2021·0 cites·3 claims
- 0571US10982190B2Genetically modified stem cellsSDF BIOPHARMA INC·Filed 2020·Granted Apr 20, 2021·0 cites·15 claims
- 0669US11981928B2Methods for reducing elevated glucose levelsSDF BIOPHARMA INC·Filed 2018·Granted May 14, 2024·0 cites·5 claims
- 0755US2024024371A1Treating diabetesSDF BIOPHARMA INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →